Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:45 PM
Ignite Modification Date:
2025-12-24 @ 9:45 PM
NCT ID:
NCT06655532
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with heart failure with preserved ejection fraction according to 2021 ESC guidelines for Heart Failure, with N-terminal pro-B-type natriuretic peptide (NT-proBNP) \>125 pg/mL, inthe last month.
* Stable symptomatic heart failure patients (New York Heart Association functional class II-III) during the last month.
* Age ≥ 60 years old.
* The participant is willing to give informed consent to participate in the study.
* SARC-F score ≥4 points.
Exclusion Criteria:
* Inability to perform a valid baseline cardiopulmonary exercise test.
* Cardiac pacemaker.
* Significant primary moderate-to-severe valve disease.
* Effort angina or signs of ischemia during CPET.
* Primary cardiomyopathies.
* Cardiac transplantation.
* Any other comorbidity with a life expectancy of less than one year.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
60 Years
Study:
NCT06655532
Study Brief:
Protocol Section:
NCT06655532